About Christopher Gibbons
Christopher Gibbons is a chief scientific officer, co-founder and director at CND Life Sciences.
Christopher Gibbons first appears on SEC filings in 2021.
Experience
This experience comes from Christopher Gibbons's profile and from SEC filings. For roles taken from filings, the years are when the filings name Christopher Gibbons in the role, so the role may have started earlier or lasted longer.
CND Life Sciences, Inc. Current
Chief Scientific Officer, Co-Founder and director
Chief Science Officer (2019 – Present)
2019 – Present · Scottsdale, AZ
Skin biopsy testing helps clinicians assess patients for Parkinson’s disease and related disorders.
HC
Harvard Medical School, Beth Israel Deaconess Medical Center Current
Professor of Neurology (2024 – Present)
Director, Harvard Catalyst Clinical and Translational Research Course (2014 – 2021)
2014 – Present
BC
Beth Israel Deaconess Medical Center
Associate Professor of Neurology, Harvard Medical School
2004 – 2024
Key Colleagues at Startups
The people Christopher Gibbons works with at each company, as listed on that company's latest Form D.
CND Life Sciences, Inc. · Form D/A, Aug 3, 2026
Richard Morello
Chief Executive Officer and director
Peter Harris
Board Chair
Enrique Carrazana
Board Director
Jack Seaver
Board Director
Todd Levine
Chief Medical Officer, Co-Founder and director